Hilma Biocare Turinabol

Turinabol is an oral steroid that was developed in the early 60s.

This steroid had a predominantly anabolic effect on the body, which was combined with a relatively small androgenic effect. On a scale of 100%, this effect is 6%, anabolic 53%. (For comparison: the androgenic effect of Dianabol is 45%, the anabolic somewhere around 90%). Therefore, Turinabol had a weaker effect than Dianabol and did not lead to fast accumulation of strength and muscle mass. The results in the increase in muscle mass and a good increase in strength appeared in the case of a sufficiently long-term use of the drug. At the same time, the athlete did not form a swollen appearance, as when taking Testosterone, Dianabol and Anadrol.

Turinabol is an appropriate pre-competition steroid for both men and women, because it quickly decomposes in the body and its decay products are excreted in the urine in the shortest possible time.

Already after 10 days of taking Turinabol at a dose of 20 mg per day, suppression of the own production of testosterone is observed, which returns to normal after 5 days after stopping the drug and even subsequently increases. Relatively fast recovery of own testosterone production apparently lies in the fact that Turinabol, in comparison with other steroids, reduces the level of androgenic testosterone to 60-70% of the norm, while Dianabol, for example, to 30-40%.

Possible side effects of Turinabol are dose related and differ by sex of user. In women, depending on the predisposition to masculinization, their appearance was caused by doses of more than 20 mg per day and long-term use of the drug. In men - their own production of testosterone could be greatly reduced.